Search Results - "Holst, R."

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children by Wollenberg, A., Christen‐Zäch, S., Taieb, A., Paul, C., Thyssen, J.P., Bruin‐Weller, M., Vestergaard, C., Seneschal, J., Werfel, T., Cork, M.J., Kunz, B., Fölster‐Holst, R., Trzeciak, M., Darsow, U., Szalai, Z., Deleuran, M., Kobyletzki, L., Barbarot, S., Heratizadeh, A., Gieler, U., Hijnen, D.J., Weidinger, S., De Raeve, L., Svensson, Å., Simon, D., Stalder, J.F., Ring, J.

“…Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease. The diagnosis is made using evaluated clinical criteria. Disease activity and…”
Get full text

TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis by Nygaard, U., Hvid, M., Johansen, C., Buchner, M., Fölster-Holst, R., Deleuran, M., Vestergaard, C.

“…Background Recent years have seen growing interest in identifying new biomarkers in atopic dermatitis (AD) that could serve as indicators of disease severity…”
Get full text

Increased efficacy of omalizumab in atopic dermatitis patients with wild‐type filaggrin status and higher serum levels of phosphatidylcholines by Hotze, M., Baurecht, H., Rodríguez, E., Chapman‐Rothe, N., Ollert, M., Fölster‐Holst, R., Adamski, J., Illig, T., Ring, J., Weidinger, S.

“…Omalizumab, a monoclonal antibody targeting IgE, is an established therapy for severe allergic asthma and has shown efficacy in chronic spontaneous urticaria…”
Get full text

Severe systemic juvenile xanthogranuloma is an indication for systemic therapy by Fölster‐Holst, R.

“…Linked Article: Maintz et al. Br J Dermatol 2017; 176:481–487…”
Get full text

The European treatment of severe atopic eczema in children taskforce (TREAT) survey by Proudfoot, L.E., Powell, A.M., Ayis, S., Barbarot, S., Baselga Torres, E., Deleuran, M., Fölster-Holst, R., Gelmetti, C., Hernández-Martin, A., Middelkamp-Hup, M.A., Oranje, A.P., Logan, K., Perkins, M., Patrizi, A., Rovatti, G., Schofield, O., Spuls, P., Svensson, Å., Vestergaard, C., Wahlgren, C.-F., Schmitt, J., Flohr, C.

“…Summary Background There is a paucity of evidence for the use of systemic agents in children with atopic eczema refractory to conventional therapy, resulting…”
Get full text

Effects of a protein‐free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients by Wollenberg, A., Fölster‐Holst, R., Saint Aroman, M., Sampogna, F., Vestergaard, C.

“…Atopic dermatitis (AD) is a common, highly pruritic, chronic inflammatory skin disease. Dysfunction of the epidermal barrier is witnessed by an increased…”
Get full text

Analysis of the structure and function of the epidermal barrier in patients with ichthyoses—clinical and electron microscopical investigations by Fölster‐Holst, R., Naß, C., Dähnhardt‐Pfeiffer, S., Freitag‐Wolf, S.

“…Background Ichthyoses are pathogenetically characterized by a pronounced disorder of the epidermal barrier. Clinically, hyperkeratosis, severe scaling and…”
Get full text

European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period by Vestergaard, C., Wollenberg, A., Barbarot, S., Christen‐Zaech, S., Deleuran, M., Spuls, P., Flohr, C., Trzeciak, M., von Kobyletzki, L., Seneschal, J., Paul, C., Bieber, T., Werfel, T., Fölster‐Holst, R., Darsow, U., Gieler, U., Svensson, Å., Cork, M., Stalder, J.‐F., De Raeve, L., Kunz, B., Simon, D., Chernyshov, P., Hijnen, D., Gelmetti, C., Ring, J., Taieb, A., de Bruin‐Weller, M., Thyssen, J.P.

“…Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age…”
Get full text

Dermoscope‐guided lesional biopsy to diagnose EMA+ CK7+ CK20+ extramammary Paget's disease with an extensive lesion by Chuh, A., Zawar, V., Fölster‐Holst, R.

Get full text

From Triazines to Heptazines: Deciphering the Local Structure of Amorphous Nitrogen-Rich Carbon Nitride Materials by Holst, James R, Gillan, Edward G

“…Nitrogen-rich carbon nitride (CN x , x ≥ 1) network materials have been produced as disordered structures by a variety of precursor-based methods, many that…”
Get full text

Management of atopic dermatitis: are there differences between children and adults? by Fölster-Holst, R.

“…Atopic dermatitis (AD) usually begins during infancy. In its classical form infantile AD involves the scalp, the face and the extensor surfaces of the…”
Get full text

Childhood atopic dermatitis—Brain‐derived neurotrophic factor correlates with serum eosinophil cationic protein and disease severity by Fölster‐Holst, R., Papakonstantinou, E., Rüdrich, U., Buchner, M., Pite, H., Gehring, M., Kapp, A., Weidinger, S., Raap, U.

“…Several studies have shown that neurotrophins including brain‐derived neurotrophic factor (BDNF) play a role in chronic inflammatory skin diseases such as…”
Get full text

Stakeholders’ views on an institutional dashboard with metrics for responsible research by Haven, Tamarinde L, Holst, Martin R, Strech, Daniel

“…Concerns about research waste have fueled debate about incentivizing individual researchers and research institutions to conduct responsible research. We…”
Get full text

Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts by Ring, J., Worm, M., Wollenberg, A., Thyssen, J.P., Jakob, T., Klimek, L., Bangert, C., Barbarot, S., Bieber, T., Bruin‐Weller, M.S., Chernyshov, P.V., Christen‐Zaech, S., Cork, M., Darsow, U., Flohr, C., Fölster‐Holst, R., Gelmetti, C., Gieler, U., Gutermuth, J., Heratizadeh, A., Hijnen, D.J., Kobyletzki, L.B., Kunz, B., Paul, C., De Raeve, L., Seneschal, J., Simon, D., Spuls, P.I., Stalder, J.F., Svensson, A., Szalai, Z., Taieb, A., Torrelo, A., Trzeciak, M., Vestergaard, C., Werfel, T., Weidinger, S., Deleuran, M.

Get full text

European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics by Thyssen, J.P., Vestergaard, C., Barbarot, S., Bruin‐Weller, M.S., Bieber, T., Taieb, A., Seneschal, J., Cork, M.J., Paul, C., Flohr, C., Weidinger, S., Trzeciak, M., Werfel, T., Heratizadeh, A., Darsow, U., Simon, D., Torrelo, A., Chernyshov, P.V., Stalder, J.‐F., Gelmetti, C., Szalai, Z., Svensson, Å., Kobyletzki, L.B., De Raeve, L., Fölster‐Holst, R., Christen‐Zaech, S., Hijnen, D.J., Gieler, U., Gutermuth, J., Bangert, C., Spuls, P.I., Kunz, B., Ring, J., Wollenberg, A., Deleuran, M.

Get full text

Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score by Stalder, J.‐F., Aubert, H., Anthoine, E., Futamura, M., Marcoux, D., Morren, M.‐A., Trzeciak, M., Szalai, Z., Veres, K., Deleuran, M., Vestergaard, C., Boralevi, F., Chu, C.‐Y., De Raeve, L., Svensson, Å., Fölster‐Holst, R., Buchner, M., Takaoka, R., Aoki, V., Chernyshov, P., Chernyshova, L., Murrell, D. F., Zhao, C., Mckinster, C. D., Von Kobyletzky, L., Eichenfield, L., Totri, C., Lio, P., Seneschal, J., Moret, L., Barbarot, S.

“…Background Adherence to topical corticosteroids (TCS) is essential for the effective treatment of atopic dermatitis but can be limited by concerns about their…”
Get full text

Rhodoid naevus syndrome: why is this name preferable to ‘capillary malformation–arteriovenous malformation’? by Panzer, R., Happle, R., Fölster‐Holst, R.

Get full text

Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis by Jensen, J. M., Scherer, A., Wanke, C., Bräutigam, M., Bongiovanni, S., Letzkus, M., Staedtler, F., Kehren, J., Zuehlsdorf, M., Schwarz, T., Weichenthal, M., Fölster-Holst, R., Proksch, E.

“…To cite this article: Jensen JM, Scherer A, Wanke C, Bräutigam M, Bongiovanni S, Letzkus M, Staedtler F, Kehren J, Zuehlsdorf M, Schwarz T, Weichenthal M,…”
Get full text

Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study by Ott, H, Sieber, J, Brehler, R, Fölster-Holst, R, Kapp, A, Klimek, L, Pfaar, O, Merk, H

“…Data supporting a carry-over effect with sublingual immunotherapy (SLIT) are scarce. This randomized, double-blind, placebo-controlled study evaluated the…”
Get full text

Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial by Schmitt, J., Schäkel, K., Fölster-Holst, R., Bauer, A., Oertel, R., Augustin, M., Aberer, W., Luger, T., Meurer, M.

“…Summary Background  Patients with severe eczema frequently receive systemic glucocorticosteroids. The efficacy of prednisolone and other steroids, however, has…”
Get full text